FKBP14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.103800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.755600E-01
Normal-vs-Stage2
5.537600E-01
Normal-vs-Stage3
8.933800E-01
Normal-vs-Stage4
1.997650E-01
Stage1-vs-Stage2
4.271600E-01
Stage1-vs-Stage3
8.809600E-01
Stage1-vs-Stage4
7.866200E-02
Stage2-vs-Stage3
6.089800E-01
Stage2-vs-Stage4
1.812410E-01
Stage3-vs-Stage4
1.574570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.272600E-01
Normal-vs-AfricanAmerican
4.520400E-01
Normal-vs-Asian
9.257200E-01
Caucasian-vs-AfricanAmerican
2.434400E-01
Caucasian-vs-Asian
4.543600E-01
AfricanAmerican-vs-Asian
2.124600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.522800E-01
Normal-vs-Female
5.451400E-01
Male-vs-Female
8.425000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.994800E-01
Normal-vs-Age(41-60Yrs)
3.527200E-01
Normal-vs-Age(61-80Yrs)
6.993200E-01
Normal-vs-Age(81-100Yrs)
9.913800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.704600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.973400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.524600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.309560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.278000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.598000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.868800E-01
Normal-vs-Daily Drinker
4.791800E-01
Normal-vs-Weekly Drinker
3.286800E-01
Normal-vs-Occasional Drinker
6.381800E-01
Normal-vs-Social Drinker
4.692200E-01
Non Drinker-vs-Daily Drinker
1.749370E-01
Non Drinker-vs-Weekly Drinker
3.631500E-02
Non Drinker-vs-Occasional Drinker
2.307600E-01
Non Drinker-vs-Social Drinker
1.151980E-01
Daily Drinker-vs-Weekly Drinker
1.578480E-03
Daily Drinker-vs-Occasional Drinker
4.811900E-02
Daily Drinker-vs-Social Drinker
3.501900E-02
Weekly Drinker-vs-Occasional Drinker
5.290800E-01
Weekly Drinker-vs-Social Drinker
7.241200E-01
Occasional Drinker-vs-Social Drinker
4.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.791200E-01
Normal-vs-Grade 2
8.095800E-01
Normal-vs-Grade 3
8.019800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.607570E-02
Grade 1-vs-Grade 3
4.086000E-02
Grade 1-vs-Grade 4
6.791200E-01
Grade 2-vs-Grade 3
7.705600E-01
Grade 2-vs-Grade 4
8.095800E-01
Grade 3-vs-Grade 4
8.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.884600E-01
Normal-vs-NonDiabetic
7.323800E-01
Diabetic-vs-NonDiabetic
6.059600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.163200E-01
Normal-vs-NoPancreatitis
6.755400E-01
Pancreatitis-vs-NoPancreatitis
6.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.765800E-01
Normal-vs-N1
5.074000E-01
N0-vs-N1
4.169800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.317200E-01
Normal-vs-TP53-NonMutant
7.835200E-01
TP53-Mutant-vs-TP53-NonMutant
3.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
